2nd Jul 2012 07:00
2 July 2012
Immunodiagnostic Systems Holdings plc
Patrick Dahlen Appointed as Chief Executive Officer
Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, today announces that Patrik Olof Dahlen, a current Non-executive member of the Board, has been appointed Chief Executive Officer with immediate effect.
Patrik, aged 50, has substantial diagnostic and international industry expertise gained as Chief Executive Officer of Dako and at Perkin Elmer through to his progression to President of Life Sciences. At Dako, Patrik conducted a significant strategic repositioning of the company as a cancer diagnostics provider and a leader in companion diagnostics. As President of Life Sciences at Perkin Elmer, Patrik was instrumental in building the company's diagnostic business with a niche focus on diagnostic systems for neonatal and prenatal screening.
Most recently, Patrik acted as CEO for Neurosearch with the specific task of optimising the commercialisation strategy and establishing a global partnership for the Company's lead product, Huntexil®.
Dr Antony Martin, Non-executive Chairman of Immunodiagnostic Systems, said: "I am delighted that Patrik has stepped up to the role of Chief Executive Officer. Patrik brings a wealth of international diagnostics expertise which the Board has been benefiting from in his capacity as a Non-executive Director and we look forward to working with Patrik in the continued development and execution of the next phase of growth at IDS."
The following disclosures are made in accordance with AIM rule 17 and Schedule 2 paragraph (g) of the AIM Rules:
Patrik Dahlen is currently a director of QuantiBact A/S and DiaGenic ASA and in the last five years has been a director of Dako A/S, Chempaq A/S, NeuroSearch A/S, Sophion Biosciences A/S, Olink AB, Proxeon A/S and Contura A/S.
Patrik Dahlen has a beneficial interest in 19,032 IDS ordinary shares.
For further information:
Immunodiagnostic Systems Holdings plc | Tel : +44 (0)191 519 0660 |
Dr Anthony Martin, Non-Executive Chairman |
|
Gerard Murray, Finance Director |
|
|
|
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel |
|
Dr Vijay Barathan |
|
|
|
FTI Consulting | Tel : +44 (0)207 831 3113 |
Simon Conway |
|
Mo Noonan |
|
Related Shares:
IDH.L